Testbiotech demands EU authorisation is stopped
In a letter to the EU Commission, Testbiotech is once more asking for the market authorisation of genetically engineered maize 1507 to be stopped. The reason for this letter is a statement received from the European Food Safety Authority (EFSA) concerning two Testbiotech reports. In its statement, EFSA fails to invalidate the crucial points raised by Testbiotech. The authority defends its own risk assessment but cannot disprove the substantial lack of relevant and sufficiently reliable data.
Coalition calls for the Parties to the Convention on Biological Diversity and its Cartagena Protocol on Biosafety to take action
Today sees the start of an international call by a broad coalition of organisations to stop the spread of genetically engineered organisms into the environment. The initiative says that binding regulations must be implemented to prevent the release of genetically engineered plants that can persist and invade the environment or lead to transgene flow into native populations or local varieties at centres of origin and of genetic diversity. The organisations will be approaching the Parties of the Convention on Biological Diversity (CBD) and encouraging them to become actively involved.
Today the European Patent Office (EPO) in Munich decided upon a patent held by Ovasort (UK) covering human sperm cells and the gender selection of offspring (EP1263521). Testbiotech filed an opposition because the patent violated the ethical boundaries of patent law. The opposition was successful and the patent has now been completely revoked.